Article

Evotec sold a production facility in Toulouse to Sandoz for approximately $350 million, shifting to a capital-light model and focusing on profitable core businesses. Just - Evotec Biologics received funding from the Gates Foundation to reduce biotherapeutics development costs.

A.H.T. Syngas Technology raised €2 million through a convertible bond to transition from equipment manufacturing to operating energy facilities, aiming for stable revenues in the growing syngas market.

Deutsche Telekom expects to increase dividends for 2025, driven by T-Mobile US growth and investments in fiber and 5G networks, despite high capital expenditures impacting cash flow. Current stock prices are €5.82 for Evotec, €3.90 for AHT, and €27.16 for Deutsche Telekom.